FDMT — 4D Molecular Therapeutics, Inc. | XLV Holdings | StockAdder

(FDMT)

4D Molecular Therapeutics, Inc.

Live chart and latest FDMT stock news.

Sector ETF → XLV Health Care Select

Chart powered byTradingView— professional charts for every trader.Try it free →

FDMT News

4D Molecular Therapeutics, Inc. (FDMT) Q4 Earnings and Revenues Beat Estimates

Mar 18, 2026 Stock Titan

4D Molecular (NASDAQ: FDMT) awards 219,000 stock options to company officer

Mar 27, 2026 Investing.com

VP Gupta of 4d molecular sold $3357 in FDMT stock

Mar 24, 2026 Zacks Investment Research

How Much Upside is Left in 4D Molecular Therapeutics (FDMT)? Wall Street Analysts Think 171.74%

Nov 3, 2025 simplywall.st

Institutional investors own a significant stake of 49% in 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT)

Nov 12, 2025 Quiver Quantitative

4D Molecular Therapeutics Appoints Kristian Humer as Chief Financial Officer

Nov 17, 2025 Yahoo Finance

Where is 4D Molecular Therapeutics (FDMT) Headed According to the Street?

Feb 27, 2026 Stock Titan

Vanguard amendment shows 0 shares of 4D Molecular (NASDAQ: FDMT)

Mar 26, 2026 Yahoo Finance

Why Everyone Is Watching 4D Molecular Therapeutics, Inc. (FDMT) Closely

Dec 27, 2025 Stock Titan

FDMT SEC Filings - 4D Molecular Therapeutics Inc. 10-K, 10-Q, 8-K Forms

Mar 30, 2026 Yahoo Finance

Barclays Flags M&A Tailwinds and Pricing Relief as Upside Catalysts for 4D Molecular Therapeutics, Inc. (FDMT)

Feb 2, 2026 Stock Titan

4D Molecular (NASDAQ: FDMT) awards 217,000 stock options to CLO

Mar 27, 2026 Yahoo Finance

4D Molecular Therapeutics, Inc. (FDMT) Reports Q3 Loss, Lags Revenue Estimates

Nov 10, 2025 Stock Titan

4D Molecular (NASDAQ: FDMT) VP uses share sale to cover taxes

Mar 24, 2026 Yahoo Finance

4D Molecular Therapeutics, Inc.'s (NASDAQ:FDMT) institutional investors lost 20% over the past week but have profited from longer-term gains